Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth Tech August 5, 2026 In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and…
GLP-1 Weight Loss Drugs Could Stop Cancer Progressing Says New Study Tech May 25, 2026 GLP-1 medications such as Wegovy, Ozempic and Mounjaro have already transformed treatment for obesity and Type 2 diabetes. Now, emerging…